EQA

Microbix Unveils Test Controls for Head and Neck Cancer

Retrieved on: 
Monday, March 11, 2024
Woman, EQA, Sunnybrook Health Sciences Centre, QAP, TSX, Cancer, Throat, Exhibition, Dartmouth–Hitchcock Medical Center, IHC, Quality control, Mouth, Diagnosis, Tongue, Accreditation, Histology, Palate, Papillomaviridae, HPV, OTCQX, PCR, QC, Laboratory, Research, Nose, Head and neck cancer, Medical imaging

While HPV is best known for causing cancers of the cervix in women, this virus family also causes cancer in other bodily tissues.

Key Points: 
  • While HPV is best known for causing cancers of the cervix in women, this virus family also causes cancer in other bodily tissues.
  • Such further types of HPV-driven cancer include those of the “Head and Neck,” collectively tumours inside and behind the nose, throughout the mouth (including the tongue, gums, and palate), all sections of the throat, and the voice box.
  • Unfortunately, a lack of standardized and reproducible reference samples makes it challenging to control the recommended test workflows for diagnosing such cancers.
  • These standardized and reproducible tissue-oriented test controls will then be added to Microbix’s catalogue of QAPs, expanding its activities into support of oncology workflows alongside its wide range of infectious disease test controls.

Microbix Unveils Test Control for Gastric Ulcer Disease Pathogen

Retrieved on: 
Tuesday, February 6, 2024
Poster, Product management, OTCQX, QAP, Tropical ulcer, Bacteria, MDX, Ulcer, Diagnosis, Temperature, EQA, Laboratory, TSX, Nobel Prize, QMS, Stomach, Infection, RUO, Accreditation, Helicobacter pylori, Medical device

H. pylori infection was discovered to be the cause of stomach (gastric) ulcers in the 1980’s, in what became a Nobel Prize winning health discovery.

Key Points: 
  • H. pylori infection was discovered to be the cause of stomach (gastric) ulcers in the 1980’s, in what became a Nobel Prize winning health discovery.
  • It is difficult to culture this pathogen, leading to the use of MDx methods for rapid diagnosis.
  • It is sponsored by Labquality Oy, a well-established Scandinavian clinical-lab proficiency and accreditation authority that is a Microbix customer and collaborator (https://www.labquality.com).
  • These H. pylori QAPs are now being made available on a research-use-only (RUO) basis from Microbix as part of its PROCEEDx®FLOQ® catalogue of products.

Eight Quarter Advisors Represents Lithos Engineering in Sale to GEI Consultants

Retrieved on: 
Thursday, November 9, 2023
Consulting, Banking, Professional Services, Finance, Organizational founder, Consultant, Sale, EQA, GEI, Acquisition, Lithos, Pleasure

Lithos Engineering, a Colorado-based firm with a team of 27 dedicated professionals, brings unparalleled expertise in tunnel and trenchless design and construction technology.

Key Points: 
  • Lithos Engineering, a Colorado-based firm with a team of 27 dedicated professionals, brings unparalleled expertise in tunnel and trenchless design and construction technology.
  • Their impressive portfolio of geotechnical and geological engineering solutions has garnered them immense respect in both the public and private sectors.
  • They are true professionals.”
    “We are elated to have played a central role in this transaction,” said Chris Lueth, Managing Partner of Eight Quarter Advisors.
  • The Lithos and GEI deal underscores our commitment to businesses in this niche and we look forward to continuing to represent high quality businesses that are looking for their next capital partner.”

Microbix & Labquality Create Novel Testing Accreditation Program

Retrieved on: 
Tuesday, June 20, 2023
GUD, HSV, Treponema, Accreditation, Mouth ulcer, EQA, Infection, Mpox, QAP (Colombia), Treponema pallidum, Project management, Varicella zoster virus, OTCQX, TSX, Diagnosis, Disease, Pharmaceutical industry

MISSISSAUGA, Canada and HELSINKI, Finland, June 20, 2023 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter and Labquality Oy (Labquality), a global provider of laboratory external quality assessment (“EQA”) programs, announce their creation of the world’s first program to support accreditation of clinical laboratories for detecting the pathogens most commonly causing genital ulcer disease (“GUD”).

Key Points: 
  • This novel Labquality EQA program will help ensure the proficiency of clinical labs testing to diagnose the pathogens that cause GUD.
  • In turn, Labquality has designed and is managing this GUD-oriented EQA program – which is now offered to labs in 60 countries.
  • Juha Wahlstedt, Sales Director at Labquality, commented, “We’re pleased to be employing Microbix’s innovative QAPs for this new and important EQA program.
  • Our expertise was joined to that of Labquality and Copan to ensure accurate testing and properly-directed treatment is widely available for GUD patients.”

EpicQuest Education Acquires Remaining Stake in EduGlobal College Achieving 100% Ownership Position

Retrieved on: 
Thursday, April 6, 2023
Refugee, Global Affairs Canada, Hilltop Holdings Inc., Partnership, ASEAN, Designation (law), EQA, Immigration, IRCC, Immigration, Refugees and Citizenship Canada, Student, Acquisition, DLI, Growth, Nursing, Management, LATAM

MIDDLETOWN, Ohio, April 6, 2023 /PRNewswire/ -- EpicQuest Education Group International Limited (NASDAQ: EEIQ), ("EpicQuest Education" or the "Company"), a provider of comprehensive education solutions for domestic and international students seeking college and  university degrees in the US, Canada and the UK, today announced that on March 31, 2023, its wholly-owned subsidiary that operates in the Canadian market, Highrim Holding International Limited ("Highrim"), acquired 20% of the remaining equity of EduGlobal College ("EduGlobal") from Canada EduGlobal Holdings Inc. ("Global").

Key Points: 
  • The acquisition price for the remaining 20% of the equity in EduGlobal was C$250,000 (US$186,131).
  • The acquisition of the 20% of the remaining equity in EduGlobal results in the college being 100% owned by Highrim.
  • "The consolidation of our ownership in EduGlobal College further underscores our international expansion strategy as well as our commitment to the Canadian markets," said Jianbo Zhang, Chairman and CEO.
  • "We are excited to bring EduGlobal College fully under the EpicQuest Education umbrella and believe that the college will benefit from the synergies generated by our other educational operations, with the college having significant potential for long-term growth," CEO Jianbo Zhang concluded.

New Studies at ECR 2023 Back Clinical Efficacy of Lunit's AI Solutions in Breast Cancer Diagnosis

Retrieved on: 
Thursday, February 23, 2023
Congress, Breast cancer, EQA, Cancer, Diagnosis, Mammography, ECR, Research, Radiology, FDA, Abstract, AI, Karolinska Institute, Medical device, Medical imaging, European

In particular, 5 of the abstracts to be presented will highlight the effectiveness of Lunit's AI solutions for breast cancer diagnosis.

Key Points: 
  • In particular, 5 of the abstracts to be presented will highlight the effectiveness of Lunit's AI solutions for breast cancer diagnosis.
  • One of the studies selected for oral presentation will feature Lunit INSIGHT DBT, Lunit's AI solution for digital breast tomosynthesis.
  • Other studies include findings from comparing the AI solution's performance to human readers and another AI system.
  • "We are pleased to return to ECR this year to showcase new findings that demonstrate the clinical effectiveness of Lunit's AI solutions for breast cancer diagnosis," said Brandon Suh, CEO of Lunit.

EpicQuest Education Announces Operations Update

Retrieved on: 
Thursday, January 5, 2023
Davis College, ASEAN, Partnership, Electronic portfolio, Northeastern University, Isabela State University, English language, MUR, Business, SUC, Commission on English Language Program Accreditation, Bachelor, Philippines, International College, Acquisition, College of Professional Studies, Growth, University, Algoma University, TTPA, PSB Academy, ICBT Campus, EQA, College, ESC Rennes School of Business, COVID-19, Student, Global Affairs Canada, Trinity Western University, Trustee, Tutoring, Management, Medicine, LATAM

MIDDLETOWN, Ohio, Jan. 5, 2023 /PRNewswire/ -- EpicQuest Education Group International Limited (NASDAQ: EEIQ), (the "Company" or "EpicQuest Education"), a provider of comprehensive education solutions for domestic and international students interested in college and university programs in the US, Canada and the UK, today announced an operations update.

Key Points: 
  • MIDDLETOWN, Ohio, Jan. 5, 2023 /PRNewswire/ -- EpicQuest Education Group International Limited (NASDAQ: EEIQ), (the "Company" or "EpicQuest Education"), a provider of comprehensive education solutions for domestic and international students interested in college and university programs in the US, Canada and the UK, today announced an operations update.
  • We believe that our strategic plan will optimally grow the company and lead to superior educational outcomes for our students," commented Jianbo Zhang, Chairman and CEO of EpicQuest Education.
  • An update of our owned and operated colleges as well as our recruiting relationship with the Miami University Regional Campuses follows.
  • EduGlobal College was approved for Education Quality Assurance (EQA) designation in British Columbia, Canada through May 31, 2023.

BC Platforms, Euformatics and Oncompass Medicine form a partnership to develop oncology NGS workflows for buyer consortium of seven major European hospitals

Retrieved on: 
Wednesday, May 18, 2022
PCP, Software, NGS, SME, Medicine, Medical University of Graz, University of Florence, Pathology, Patient, Erasmus MC, Contract, Workflow, Association, H2020, EQA, Medical school, BC, Research, ELIXIR, DIGITALEUROPE, Partnership, Cancer Research Institute, Program, University, Hospital, Neoplasm, Union, BCP, Technology, Drug development, Precision medicine, Quality control, Intelligence, Ng Hui Ern, DNA sequencing, Cancer, University of Milano-Bicocca, Classification, IP, CEO, Pharmaceutical industry, Medical device, Medical imaging, EU, European, Central Europe

The buyer consortium, represented by the Medical University Graz, evaluated all proposals, and awarded a contract to the consortium of BC Platforms, Euformatics and Oncompass Medicine.

Key Points: 
  • The buyer consortium, represented by the Medical University Graz, evaluated all proposals, and awarded a contract to the consortium of BC Platforms, Euformatics and Oncompass Medicine.
  • The joint proposal by BC Platforms, Euformatics and Oncompass Medicine was evaluated by leading experts and selected for funding.
  • Oncompass was the first to develop a software as a medical device based on artificial intelligence that proved to improve therapeutic decisions in precision oncology.
  • Oncompass also provides end-to-end services for oncology centers that wish to provide precision oncology to their patients.

BC Platforms, Euformatics and Oncompass Medicine form a partnership to develop oncology NGS workflows for buyer consortium of seven major European hospitals

Retrieved on: 
Wednesday, May 18, 2022
PCP, Software, NGS, SME, Medicine, Medical University of Graz, University of Florence, Pathology, Patient, Erasmus MC, Contract, Workflow, Association, H2020, EQA, Medical school, BC, Research, ELIXIR, DIGITALEUROPE, Partnership, Cancer Research Institute, Program, University, Hospital, Neoplasm, Union, BCP, Technology, Drug development, Precision medicine, Quality control, Intelligence, Ng Hui Ern, DNA sequencing, Cancer, University of Milano-Bicocca, Classification, IP, CEO, Pharmaceutical industry, Medical device, Medical imaging, EU, European, Central Europe

The buyer consortium, represented by the Medical University Graz, evaluated all proposals, and awarded a contract to the consortium of BC Platforms, Euformatics and Oncompass Medicine.

Key Points: 
  • The buyer consortium, represented by the Medical University Graz, evaluated all proposals, and awarded a contract to the consortium of BC Platforms, Euformatics and Oncompass Medicine.
  • The joint proposal by BC Platforms, Euformatics and Oncompass Medicine was evaluated by leading experts and selected for funding.
  • Oncompass was the first to develop a software as a medical device based on artificial intelligence that proved to improve therapeutic decisions in precision oncology.
  • Oncompass also provides end-to-end services for oncology centers that wish to provide precision oncology to their patients.

Mercedes-Benz Cars Aims to Slash CO2 Emissions by More Than 50 Percent by End of This Decade

Retrieved on: 
Monday, April 11, 2022
Automotive, Automotive Manufacturing, Environment, Manufacturing, Performance & Special Interest, Alternative Energy, Energy, Adoption, Risk, EQC, Cobalt, EQE, Capital expenditure, EQA, ASI, Leadership, Wind, EQV, KPI, Board, CO2, EQT, Mining, Social, ESG, Research, Recycling, WLTP, Plant, Bev, EQB, LFP, Woman, Conference, COP26, Lithium, Carbon, Electricity, Mercedes-Benz, Diversity, Technology, Twitter, EQS, Time, Climate, Social Security Government Pension Offset, AG, Environment, PET, Mercedes, Power purchase agreement, Renewable energy, Car dealership, EU

The company aims to at least halve CO2 emissions per passenger car over the lifecycle by the end of this decade compared to 2020 levels.

Key Points: 
  • The company aims to at least halve CO2 emissions per passenger car over the lifecycle by the end of this decade compared to 2020 levels.
  • In the lifecycle of an electric vehicle, using renewable energy for charging is a significant lever for helping to avoid CO2 emissions.
  • With the current EU electricity mix, supply chain and production account for more than half of the lifecycle CO2 emissions.
  • Additional CO2 savings are expected to be achieved through further measures - e.g., by improving the anode and cathode production process.